DataM Intelligence | competitive Intelligence Uveal Melanoma enters a new era with novel therapies like KIMMTRAK and HEPZATO, as next-gen t ...

Multiple sclerosis (MS) includes both peripheral and central nervous system (CNS) inflammation, and an anti-inflammatory ...

Primary sclerosing cholangitis, PSC in short, is a rare liver disease that destroys the bile ducts. It is a severe condition ...

There’s a lot of stigma around Mounjaro and a recent study found that people think weight loss that’s brought on by weight ...

CAR-T cells are specialized immune cells genetically modified to recognize and attack cancer cells. Researchers at Nagoya ...

PARIS, France I June 10, 2025 I As metabolic dysfunction-associated steatohepatitis (MASH) emerges as one of the most dangerous and underdiagnosed drivers of ...

Visceral fat, commonly seen in midlife "dad bods" surrounds vital organs, increases inflammation, disrupts hormones, and ...

Scientists have pursued the illusive dream of slowing aging not only to extend life but also to guarantee good health during those extra years. Now, from an improbable location your medicine cabinet ...

As kava gains popularity for its stress-relieving benefits, experts warn that safe use depends on tradition-informed practices, scientific evidence, and robust product regulation to prevent potential ...

Aleniglipron’s tolerability could be a differentiator for Structure Therapeutics, but its efficacy lags competitors. Read why ...

当前全球肿瘤免疫治疗市场预计2025年超2000亿美元，NCR3作为NK细胞激活“开关”，成为药企必争之地。跨国药企如罗氏、默沙东依托PROTAC技术探索调控，国内药企如药明康德、三生国健加速重组蛋白研发，NCR3靶点正从实验室迈向产业化，掀起研发热潮。 自然细胞毒性触发受体3（Natural Cytotoxicity Triggering Receptor 3，NCR3），又被称为NKp30，其 ...